Siina

Siimutin is a drug that belongs to the group of cytostatic drugs and is used to treat cancer. The manufacturer of this drug is Bristol-Myers Squibb, which is an American company that also cooperates with an Italian manufacturer.

Siimutin actively affects the DNA of tumor tissue cells, causing their mutation and death. This drug is used both for extracerebral and intracerebral tumors. Siimutin is also prescribed for the treatment of melanoma, as well as other malignant diseases.

The action of Siimutin is activated in the gastrointestinal tract and reaches its maximum concentration in the blood within an hour after consumption. The half-life of the drug varies from 3 to 5 hours. Despite the fact that Siimutin is used to treat various diseases, it has a list of contraindications. It is strictly prohibited for pregnant women and breastfeeding mothers. The use of this drug is also contraindicated for people with liver problems, pregnant women, people suffering from leukopenia, thrombopenia or any type of allergy. In addition, this drug is not recommended for elderly people due to the high risk of kidney failure.